Object Details
maker
Genentech, Inc.
Description (Brief)
(From box) For single-use IV administration only.
(From insert)
RITUXAN is a CD20-directed cytolytic antibody indicated for the treatment of patients with:
--Non-Hodgkin's Lymphoma
--Chronic Lymphocytic Leukemia
--Rheumatoid Arthritis in combination with methotrexate in adult patients with moderately-to severely-active RA who have inadequate response to one or more TNF antagonist therapies
-Wegener's Granulomatosis and Microscopic Polyangiitis in adult patients in combination with glucocorticoids
Location
Currently not on view
Credit Line
Gift of Genentech, Inc.
date made
ca 2013
product expiration date
2015-03
ID Number
2013.0069.10
catalog number
2013.0069.10
accession number
2013.0069
Object Name
pharmaceutical
biological
Physical Description
glass (overall material)
plastic (overall material)
cardboard (overall material)
metal (overall material)
rituximab, 100mg/10mL (overall ingredient)
Measurements
overall: 1 1/2 in x 2 3/4 in x 4 1/2 in; 3.81 cm x 6.985 cm x 11.43 cm
overall: 4 5/8 in x 2 3/4 in x 1 1/2 in; 11.7475 cm x 6.985 cm x 3.81 cm
place made
United States: California, South San Francisco
See more items in
Medicine and Science: Medicine
Health & Medicine
The Antibody Initiative
Antibody Initiative: Monoclonal Antibodies
Data Source
National Museum of American History
Link to Original Record
Record ID
nmah_1445203